Sung-Han Yoon
Interventional Cardiology Hackensack, NJ Medical Doctor
NPI 1649867979 CMS profile 10353979
30 Prospect Ave, Hackensack, NJ 07601
General payments
$104,923
Research payments
$2,000
Ownership & investment interest
$0
Through program year 2025, Sung-Han Yoon of Hackensack, NJ is reported in the CMS Open Payments database as having received $104,923 across 246 general payments and $2,000 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
General payments for this record sit in the 92nd percentile of Interventional Cardiology profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
6 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $47,831 | 92 | |
| 2024 | General | $52,850 | 46 | |
| 2023 | General | $2,676 | 43 | |
| 2023 | Research | $2,000 | 1 | |
| 2022 | General | $1,279 | 52 | |
| 2021 | General | $288 | 13 |
Beside peers
- Sung-Han Yoon
- Interventional Cardiology median
- Middle half of Interventional Cardiology
- National median
In program year 2025, general payments to Sung-Han Yoon were reported at $47,831. Among 6,173 Interventional Cardiology profiles paid that year, the median was $1,092 and the middle half received between $366 and $3,019.
Show as a table
| Year | Sung-Han Yoon | Interventional Cardiology median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $0 | $1,097 | $329–$3,048 | $163 |
| 2020 | $0 | $473 | $161–$1,480 | $114 |
| 2021 | $288 | $677 | $233–$1,827 | $132 |
| 2022 | $1,279 | $978 | $333–$2,724 | $149 |
| 2023 | $2,676 | $1,136 | $382–$2,986 | $160 |
| 2024 | $52,850 | $1,181 | $395–$3,326 | $164 |
| 2025 | $47,831 | $1,092 | $366–$3,019 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Billing to Medicare
Part B · data year 2024 · 45 billing codesPaid by Medicare
$70,093
Medicare patients
138
Services billed
332
| Condition among their Medicare patients | Relative to the most common | Share of patients |
|---|---|---|
| High blood pressure | 75% | |
| Heart failure | 75% | |
| Ischemic heart disease | 75% | |
| Atrial fibrillation | 61% | |
| Diabetes | 59% | |
| Chronic kidney disease | 59% | |
| Arthritis | 52% | |
| COPD | 46% |
Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.
Records
247 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Interventional Cardiology in New Jersey
Ankitkumar Patel
Interventional Cardiology · Glen Ridge, NJ
Ramin Hastings
Interventional Cardiology · Hasbrouck Heights, NJ
Michael Lim
Interventional Cardiology · Hackensack, NJ
Darshan Godkar
Interventional Cardiology · Cedar Knolls, NJ
Ryan Kaple
Interventional Cardiology · Hackensack, NJ
Matthew Saybolt
Interventional Cardiology · Eatontown, NJ
Related records
Interventional Cardiology in New Jersey
Practitioners in the same specialty and state, ranked by reported value.
All Interventional Cardiology
Everyone recorded under this specialty, nationwide.
Doctors in New Jersey
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.